Jenscare Scientific Co., Ltd. (HKG:9877)
Hong Kong · Delayed Price · Currency is HKD 8.15
-0.14 (-1.69%)
May 29, 2026, 4:08 PM HKT
Jenscare Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -271.23 | -177.51 | -371.74 | -439.31 | -500.52 |
Depreciation & Amortization | 13.5 | 12.3 | 11.57 | 8.86 | 5.11 |
Other Amortization | 0.65 | 0.54 | 0.49 | 0.34 | 0.15 |
Loss (Gain) From Sale of Assets | 0.04 | 0.09 | 0.01 | 0.01 | 0.01 |
Asset Writedown & Restructuring Costs | 0.29 | 6.71 | - | - | - |
Loss (Gain) From Sale of Investments | -1.75 | -10.84 | 0.17 | -0.72 | -6.49 |
Loss (Gain) on Equity Investments | - | - | -18.95 | -16.17 | -1.34 |
Stock-Based Compensation | 96.85 | 5.7 | 205.39 | 317.88 | 366.51 |
Provision & Write-off of Bad Debts | 1.97 | - | - | - | - |
Other Operating Activities | 18.22 | -1.21 | -9.85 | -36.01 | 6.74 |
Change in Accounts Receivable | -8.81 | - | - | - | - |
Change in Inventory | 7.53 | -12.21 | -18.23 | -5.22 | -3.15 |
Change in Accounts Payable | 13.05 | -4.24 | 5.38 | 2.51 | 4.66 |
Change in Other Net Operating Assets | 54.69 | -36.88 | -26.68 | 9.36 | -13.58 |
Operating Cash Flow | -75 | -217.55 | -222.44 | -158.48 | -141.89 |
Capital Expenditures | -3.24 | -71.26 | -78.2 | -21.66 | -13.28 |
Sale of Property, Plant & Equipment | - | - | 0.02 | - | - |
Sale (Purchase) of Intangibles | -1.83 | -0.43 | -0.43 | -2.14 | -2.08 |
Sale (Purchase) of Real Estate | - | - | - | -25.75 | - |
Investment in Securities | 11.75 | 77.28 | 436.75 | -97.03 | -459.73 |
Other Investing Activities | -0.71 | - | - | - | 0.01 |
Investing Cash Flow | 5.97 | 5.59 | 358.13 | -146.58 | -475.07 |
Short-Term Debt Issued | - | 3.2 | - | - | - |
Long-Term Debt Issued | - | 16.24 | 40.75 | - | - |
Total Debt Issued | - | 19.44 | 40.75 | - | - |
Long-Term Debt Repaid | -18.84 | -2.89 | -3.02 | -1.92 | -2.36 |
Total Debt Repaid | -18.84 | -2.89 | -3.02 | -1.92 | -2.36 |
Net Debt Issued (Repaid) | -18.84 | 16.54 | 37.73 | -1.92 | -2.36 |
Issuance of Common Stock | - | - | 22.89 | 189.35 | 1,078 |
Repurchase of Common Stock | -0.36 | -127.25 | -5.04 | - | - |
Other Financing Activities | -1.41 | -0.03 | 0.86 | 1.5 | -0.37 |
Financing Cash Flow | -20.61 | -110.74 | 56.44 | 188.93 | 1,075 |
Foreign Exchange Rate Adjustments | -8.94 | 0.87 | 8.33 | 42.91 | -6.84 |
Net Cash Flow | -98.59 | -321.84 | 200.46 | -73.23 | 451.52 |
Free Cash Flow | -78.24 | -288.81 | -300.64 | -180.14 | -155.17 |
Free Cash Flow Margin | -86.37% | - | - | - | - |
Free Cash Flow Per Share | -0.18 | -0.71 | -0.72 | -0.49 | -0.46 |
Cash Interest Paid | 1.41 | 0.16 | 0.14 | - | - |
Levered Free Cash Flow | -26.24 | -207.91 | -155.47 | -12.21 | 53.01 |
Unlevered Free Cash Flow | -25.7 | -207.73 | -155.38 | -12.14 | 53.09 |
Change in Working Capital | 66.46 | -53.32 | -39.53 | 6.65 | -12.07 |